These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 29889411)

  • 1. Hepatitis B vaccination: evolution of hepatitis B vaccine coverage; public health impact, efficiency limits, New vaccines.
    Denis F
    Bull Acad Natl Med; 2016 Jan; 200(1):33-45. PubMed ID: 29889411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Public health impact of Infanrix hexa (DTPa-HBV-IPV/Hib) reimbursement: A study programme in France. Part 1: Evolution of hepatitis B vaccine coverage rates in infants aged less than 27 months, in the general population - the PopCorn study.
    Gaudelus J; Vié le Sage F; Dufour V; Lert F; Texier N; Pouriel M; Tehard B; Bréart G
    Rev Epidemiol Sante Publique; 2016 Feb; 64(1):23-32. PubMed ID: 26748972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of hepatitis B vaccine coverage rates in France between 2008 and 2011.
    Denis F; Cohen R; Martinot A; Stahl JP; Lery T; Le Danvic M; Gaudelus J
    Med Mal Infect; 2013 Jul; 43(7):272-8. PubMed ID: 23876204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Public health impact of Infanrix hexa™ (DTPa-HBV-IPV/Hib) reimbursement: A study programme in France. Part 2: Evolution of the acceptability of infants' vaccination against hepatitis B in general and pediatric practices - the PRALINE study.
    Vié le Sage F; Gaudelus J; Lert F; Dufour V; Texier N; Pouriel M; Schück S; Tehard B; Bréart G
    Rev Epidemiol Sante Publique; 2016 Jun; 64(3):185-94. PubMed ID: 27238163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An update after 16 years of hepatitis B vaccination in South Africa.
    Burnett RJ; Kramvis A; Dochez C; Meheus A
    Vaccine; 2012 Sep; 30 Suppl 3():C45-51. PubMed ID: 22939021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus markers among teenagers in the Araguaia region, Central Brazil: assessment of prevalence and vaccination coverage.
    Melo LV; da Silva MA; Calçada Cde O; Cavalcante SR; Souto FJ
    Vaccine; 2011 Jul; 29(32):5290-3. PubMed ID: 21605613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B vaccination status in an at-risk adult population: long-term immunity but insufficient coverage.
    Hustache S; Moyroud L; Goirand L; Epaulard O
    Eur J Clin Microbiol Infect Dis; 2017 Aug; 36(8):1483-1489. PubMed ID: 28285330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do selective immunisation against tuberculosis and hepatitis B reach the targeted populations? A nationwide register-based study evaluating the recommendations in the Norwegian Childhood Immunisation Programme.
    Feiring B; Laake I; Molden T; Håberg SE; Nøkleby H; Seterelv SS; Magnus P; Trogstad L
    Vaccine; 2016 Apr; 34(17):2015-20. PubMed ID: 26947498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Materno-fetal transmission of hepatitis B virus in Ivory Coast. Plea for mass vaccination].
    Lohouès-Kouacou MJ; Touré M; Hillah J; Camara BM; N'Dri N; Kouamé KJ; Attia Y
    Sante; 1998; 8(6):401-4. PubMed ID: 10064911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of hepatitis B immunization on prevention of mother-to-infant transmission of hepatitis B virus and on the immune response of infants towards hepatitis B vaccine.
    Zhang L; Gui XE; Teter C; Zhong H; Pang Z; Ding L; Li F; Zhou Y; Zhang L
    Vaccine; 2014 Oct; 32(46):6091-7. PubMed ID: 25240752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B vaccination in countries with low endemicity.
    Prescrire Int; 2000 Feb; 9(45):213-9. PubMed ID: 11503803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of hepatitis-B vaccination in Ivory Coast: the case of the Grand Bassam health district.
    Magoni M; Ekra KD; Aka LN; Sita KS; Kanga K
    Ann Trop Med Parasitol; 2009 Sep; 103(6):519-27. PubMed ID: 19695157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Key outcomes and addressing remaining challenges--perspectives from a final evaluation of the China GAVI project.
    Yang W; Liang X; Cui F; Li L; Hadler SC; Hutin YJ; Kane M; Wang Y
    Vaccine; 2013 Dec; 31 Suppl 9():J73-8. PubMed ID: 24331024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of hepatitis B vaccine in China and in the China GAVI Project.
    Hadler SC; Fuqiang C; Averhoff F; Taylor T; Fuzhen W; Li L; Xiaofeng L; Weizhong Y
    Vaccine; 2013 Dec; 31 Suppl 9():J66-72. PubMed ID: 24331023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of Hepatitis-B infection amongst Taiwanese university students 18 years following the commencement of a national Hepatitis-B vaccination program.
    Su FH; Chen JD; Cheng SH; Lin CH; Liu YH; Chu FY
    J Med Virol; 2007 Feb; 79(2):138-43. PubMed ID: 17177303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass vaccination against hepatitis B: the French example.
    Denis F; Levy-Bruhl D
    Curr Top Microbiol Immunol; 2006; 304():115-29. PubMed ID: 16989267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness and impact of hepatitis B virus vaccination of children with at least one parent born in a hepatitis B virus endemic country: an early assessment.
    Hontelez JA; Hahné S; Koedijk FH; de Melker HE
    J Epidemiol Community Health; 2010 Oct; 64(10):890-4. PubMed ID: 19822551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serological and molecular epidemiological outcomes after two decades of universal infant hepatitis B virus (HBV) vaccination in Nunavut, Canada.
    Huynh C; Minuk GY; Uhanova J; Baikie M; Wong T; Osiowy C
    Vaccine; 2017 Aug; 35(35 Pt B):4515-4522. PubMed ID: 28736196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eight years of hepatitis B vaccination in Colombia with a recombinant vaccine: factors influencing hepatitis B virus infection and effectiveness.
    de la Hoz F; Perez L; de Neira M; Hall AJ
    Int J Infect Dis; 2008 Mar; 12(2):183-9. PubMed ID: 17913535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevention of hepatitis A and hepatitis B by vaccination].
    Buisson Y; Meyran M
    Ann Gastroenterol Hepatol (Paris); 1995 Oct; 31(5):306-8; discussion 308-9. PubMed ID: 8572566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.